Altered Expression of the ERM Proteins in Lung Adenocarcinoma [PDF]
Masahide Tokunou+5 more
openalex +1 more source
This study reveals the tumor‐suppressive role of TRIM38 in colorectal cancer (CRC). TRIM38 is downregulated through DNA hypermethylation and correlates with unfavorable clinical features and poor prognosis. Mechanistically, TRIM38 inhibits CRC progression by promoting K48‐linked ubiquitination of CCT6A, leading to the destabilization of c‐Myc.
Yue Zhang+10 more
wiley +1 more source
Mesenchymal-epithelial transition factor exon 14 skipping mutation-positive granulocyte colony-stimulating factor-producing lung adenocarcinoma mimicking lung abscess: A case report. [PDF]
Izumiya Y+4 more
europepmc +1 more source
Posterior Subglottic Mass in a Patient With a History of Rectal Adenocarcinoma and Lung Metastases. [PDF]
Craig F, O'Sullivan Coyne G, Allen CT.
europepmc +1 more source
Transition from Squamous Cell Carcinoma to Adenocarcinoma in Adenosquamous Carcinoma of the Lung [PDF]
Hironobu Kanazawa+7 more
openalex +1 more source
POU3F3 is significantly upregulated in non‐small cell lung cancer (NSCLC). Activated ERK1 directly interacts with and phosphorylates POU3F3, facilitating its nuclear translocation in NSCLC cells. Within the nucleus, POU3F3 functions as a transcription factor to enhance ATP5PF expression, thereby increasing the activity of mitochondrial complex V and ...
Qi‐Gang Zeng+14 more
wiley +1 more source
Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent pembrolizumab. [PDF]
Saltman DL+10 more
europepmc +1 more source
Embelin cotargets SHP2 to disrupt the SHP2/GRB2/SOS complex, inhibiting cancer‐related signaling pathways such as MAPK, (PI3K)/AKT pathway, and XIAP to induce apoptosis signaling pathway, respectively, leading to synthetic lethality in KRAS‐mutant NSCLC cells both in vivo and in vitro.
Nai‐jie Fu+8 more
wiley +1 more source
In-depth analysis of immune cell landscapes reveals differences between lung adenocarcinoma and lung squamous cell carcinoma. [PDF]
Wang X, Zheng K, Hao Z.
europepmc +1 more source
Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. [PDF]
Zengin T, Önal-Süzek T.
europepmc +1 more source